Tradestie Institutional Equity Comparison Engine

CDT vs AAPG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AAPG Overall Edge

AAPG Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ascentage Pharma Group International American Depository Shares (AAPG) driven by superior Valuation, Momentum & Technical, Options & Structure while CDT counters with relative strength in Growth & Margin. Fundamentally, CDT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AAPG at 8.4x Forward P/E and -219.5% operating margin (+29.3% YoY). In options structure, CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against AAPG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AAPG
CDT N/M vs AAPG 8.4x Fwd P/E
Growth & Margin Winner CDT
Op Margin 0.0% vs -219.5% ยท YoY +0.0% vs +29.3%
Momentum & Technical Winner AAPG
1Y -86.8% vs -64.0% ยท 52W Pos 2% vs 0%
Options & Structure Winner AAPG
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
CDT NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap $507,528
1M Return +76.79%
1Y Return -86.78%
Forward P/E N/M
Unified AI Score
31.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 54.0
AAPG NASDAQ
Ascentage Pharma Group International American Depository Shares
Pharmaceutical Preparations
$11.97
-3.78% 1D
Market Cap $1.2B
1M Return -19.77%
1Y Return -64.0%
Forward P/E 8.4x
Unified AI Score
37.1 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CDT -86.78% AAPG -64.0% Spread: +23.95 pp (AAPG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CDT TTM Op. Margin: 0.0% AAPG TTM Op. Margin: -219.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDT vs AAPG. Trailing 12-month operating profitability (CDT 0.0% vs AAPG -219.5%) and valuation multiples (CDT N/M vs AAPG 8.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CDT (4) vs AAPG (6)
Institutional Metric CDT AAPG Criterion Row Winner
Market Capitalization Scale $507,528 $1.2B Larger Scale AAPG
Trailing P/E Ratio Valuation N/M 8.4x Lower Multiple AAPG
Forward P/E Ratio Valuation N/M 8.4x Lower Multiple AAPG
Revenue Growth (YoY) Growth +0.0% +29.3% Higher Growth AAPG
Operating Margin (TTM) Profitability 0.0% -219.5% Higher Margin CDT
Net Profit Margin Profitability 0.0% -228.5% Higher Margin CDT
Return on Equity (ROE) Capital Efficiency -69.7% -236.6% Higher ROE CDT
52-Week Range Position Momentum 2% ($0โ€“$11) 0% ($12โ€“$34) Stronger Trend CDT
Beta / 30D Volatility Risk Regime -17.75ฮฒ ยท 10175% Vol 1.36ฮฒ ยท 64% Vol Lower Realized Risk AAPG
Unified Institutional Score Composite Signal 31.6 / 100 (SELL) 37.1 / 100 (SELL) Higher Composite AAPG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CDT vs AAPG Buy Guide
CDT BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AAPG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AAPG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CDT nor AAPG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.